Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) |
3 Months Ended | 6 Months Ended | 12 Months Ended | |||
|---|---|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
Dec. 31, 2025 |
Dec. 31, 2024 |
|
| Net revenue | $ 173,941 | $ 196,946 | $ 377,668 | $ 488,830 | $ 1,278,994 | $ 1,498,874 |
| Cost of revenue | 31,987 | 47,768 | 33,416 | 87,744 | 219,405 | 63,144 |
| Gross margin | 141,954 | 149,178 | 344,252 | 401,086 | 1,059,589 | 1,435,730 |
| Operating expenses | ||||||
| Stock based compensation | 1,440,160 | 2,360,259 | 12,748,152 | 3,310,183 | 5,305,221 | 9,442,717 |
| Impairment of intangible assets | 35,723 | |||||
| Impairment of goodwill | 3,034 | |||||
| General and administrative | 643,864 | 19,808 | 1,360,269 | 710,997 | 1,755,745 | 1,910,480 |
| Marketing | 12,525 | 65,869 | 118,997 | 107,332 | 518,594 | 274,039 |
| Compensation | 355,384 | 293,279 | 726,192 | 822,601 | 1,564,212 | 1,941,672 |
| Research and development | (19,427) | 21,798 | 1,843 | 204,043 | ||
| Total operating expenses | 2,432,506 | 2,739,215 | 14,975,408 | 4,951,113 | 9,184,371 | 13,772,951 |
| Loss from operations | (2,290,552) | (2,590,037) | (14,631,156) | (4,550,027) | (8,124,782) | (12,337,221) |
| Other (expenses) income | ||||||
| Change in fair value of derivative liability | 368,860 | 639,644 | (992,731) | 7,836,522 | ||
| Other income | 72 | 880,044 | 2,947 | 1,068,704 | 1,154,885 | 9,474 |
| Interest expense | (723,549) | (319,155) | ||||
| Fees and penalties | (230,311) | |||||
| Gain on settlement of liabilities | 950,408 | 421,748 | 948,031 | 527,353 | ||
| Interest income (expense), net | 119,788 | (60,022) | 104,227 | (128,117) | ||
| Unrealized (loss) gain on marketable securities | (1,105,838) | (21,558) | (1,261,526) | 36,461 | 166,114 | |
| Realized loss on marketable securities | (1,824) | (1,824) | ||||
| Accretion of debt discount and issuance cost | (523,598) | (13,246) | (1,727,449) | (48,775) | (415,094) | (2,120,640) |
| Settlement of liabilities, net | 3,323,978 | 3,312,414 | ||||
| Inducement expense | (17,840) | (1,465,308) | ||||
| Gain on extinguishment of debt | 9,238 | 729,304 | 413,903 | |||
| Other (expenses) income, net | (192,132) | 1,206,966 | (1,295,950) | 1,464,864 | 2,994,756 | 7,667,210 |
| Loss before income tax provision | (2,482,684) | (1,383,071) | (15,927,106) | (3,085,163) | (5,130,026) | (4,670,011) |
| Income tax provision | ||||||
| Net loss from continuing operations | (2,482,684) | (1,383,071) | (15,927,106) | (3,085,163) | (5,130,026) | (4,670,011) |
| Net loss from discontinued operations | (89,410) | (1,379,339) | (426,993) | 4,234,525 | ||
| Net loss | (2,482,684) | (1,472,481) | (17,306,445) | (3,512,156) | (9,364,552) | (4,670,011) |
| Currency translation loss | (358) | (688) | (123,574) | |||
| Comprehensive loss | $ (2,482,684) | $ (1,472,481) | $ (17,306,445) | $ (3,512,514) | $ (9,365,240) | $ (4,793,585) |
| Per-share data | ||||||
| Weighted average common shares outstanding, basic (in Shares) | 555,189 | 128,301 | ||||
| Weighted average common shares outstanding, diluted (in Shares) | 555,189 | 128,301 | ||||
| Basic loss per share from continuing operations (in Dollars per share) | $ (2.95) | $ (2.55) | $ (19.85) | $ (6.64) | $ (9.24) | $ (36.4) |
| Diluted loss per share from continuing operations (in Dollars per share) | (2.95) | (2.55) | (19.85) | (6.64) | (9.24) | (36.4) |
| Basic loss per share from discontinued operations (in Dollars per share) | (0.16) | (1.72) | (0.92) | (7.63) | 0 | |
| Diluted loss per share from discontinued operations (in Dollars per share) | $ (0.16) | $ (1.72) | $ (0.92) | (7.63) | 0 | |
| Net loss per common share, basic (in Dollars per share) | (16.87) | (36.4) | ||||
| Net loss per common share, diluted (in Dollars per share) | $ (16.87) | $ (36.4) | ||||
| Weighted average number of common shares outstanding from continuing operations (in Shares) | 840,363 | 542,546 | 802,205 | 464,532 | ||
| Weighted average number of common shares outstanding from discontinued operations (in Shares) | 840,363 | 542,546 | 802,205 | 464,532 | ||
| Net loss attributable to noncontrolling interest | $ 2,602 | $ (134,472) | $ (398,973) | $ (169,550) | $ (1,310,081) | $ (2,555,059) |
| Net loss attributable to Creatd, Inc. | (2,485,286) | (1,338,009) | (16,907,472) | (3,342,606) | (8,054,471) | (2,114,952) |
| Deemed dividend | 384,700 | 51,673 | 384,700 | 1,363,254 | 2,071,047 | (33,017,888) |
| Net loss attributable to Creatd, Inc. common stockholders | $ (2,869,986) | $ (1,389,682) | $ (17,292,172) | $ (4,705,860) | (10,125,519) | (35,132,840) |
| Previously Reported | ||||||
| Net revenue | 1,278,994 | 1,498,874 | ||||
| Operating expenses | ||||||
| Impairment of intangible assets | 226,613 | |||||
| Other (expenses) income | ||||||
| Inducement expense | (17,840) | |||||
| Gain on extinguishment of debt | 729,304 | |||||
| Net loss from discontinued operations | (4,234,526) | |||||
| Net loss | $ (9,364,552) | $ (4,670,011) | ||||
| X | ||||||||||
- Definition Whereas, the deemed dividend is a particular amount or asset loaned to a shareholder who has a substantial share in that company, for the purpose of taxation the loaned amount is considered to be deemed dividend. The loan or advancement amount should only be provided from the accumulated profits of the company. No definition available.
|
| X | ||||||||||
- Definition Represent the amount of inducement expense. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Weighted average number of common shares outstanding from continuing operations No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Research and Development Expense (Reversal) No definition available.
|
| X | ||||||||||
- Definition The amount of settlement of vendor liabilities. No definition available.
|
| X | ||||||||||
- Definition Weighted average number of common shares outstanding from discontinued operations No definition available.
|
| X | ||||||||||
- Definition Amount of amortization expense attributable to debt discount (premium) and debt issuance costs. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate cost of goods produced and sold and services rendered during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense for employee benefit and equity-based compensation. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of expense (income) related to adjustment to fair value of warrant liability. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of gain (loss) recognized in settlement of litigation and insurance claims. Excludes claims within an insurance entity's normal claims settlement process. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of impairment loss from asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of impairment loss for finite- and indefinite-lived intangible assets and capitalized cost for software to be sold, leased, or marketed. Excludes goodwill. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount after tax of income (loss) from continuing operations attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of interest expense classified as nonoperating. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of interest income (expense) classified as nonoperating. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of realized gain (loss) on investment in marketable security. No definition available.
|
| X | ||||||||||
- Definition Amount of unrealized gain (loss) on investment in marketable security. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of Net Income (Loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of income related to nonoperating activities, classified as other. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
| X | ||||||||||
- Definition Amount of noncash expense for share-based payment arrangement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|